Comprehensive molecular profiling of newly diagnosed advanced, high-grade ovarian cancer: Unveiling BRCA1/2 mutations and genomic instability scores to advocate for public insurance coverage of genetic testing—Insights from the Hellenic Society of Medical Oncology (HeSMO) national program.
Authors
Emmanouil Saloustros,
Michalis LiontosEleni Timotheadou,
C. Andreadis,
Efthymia Skafida,
John Syrios,
A. Kalykaki,
Konstantinos Koutsoukos,
Georgios Kesisis,
Ioannis Boukovinas,
Anastasios Boutis,
Pavlos Papakotoulas,
Dimitrios Ziogas,
Sofia Karageorgopoulou,
Stylianos Giassas,
Evangelos Lianos,
N. Chatzifoti,
Fotini Papageorgiou +16 authors
,
Zacharenia Saridaki
Tip
Tip